Clinical Trials Sponsored by Sunovion

Total 184 results

Sunovion

Completed

An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia

Schizophrenia

United States, Ukraine, Russian Federation, Hungary, Romania
Sunovion

Completed

A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" Episodes

Parkinson Disease

United States
Sunovion

Completed

A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures

Epilepsy With Partial On-set Seizures

United States, Canada
Sunovion

Completed

Dasotraline Pediatric Extension Study

Attention Deficit Hyperactivity Disorder

United States
Sunovion

Completed

A Twelve Week, Open Label Extension Study in Patients With Schizophrenia

Schizophrenia

United States, Slovakia, France, Italy, Serbia, South Africa, Russian Federation
Sunovion

Completed

Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)

Epilepsy

United States
Sunovion

Completed

Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

Insomnia | Attention Deficit Hyperactivity Disorder

United States
Sunovion

Completed

Open-label Safety Study in Adults With ADHD

Adult Attention Deficit Hyperactivity Disorder

United States
Sunovion

Completed

Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic

Epilepsy

United States, Bulgaria, Czech Republic, Serbia, Ukraine
Sunovion

Completed

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex (PERSIST)

Bipolar I Disorder

United States, Croatia, Hungary, Poland, Serbia, Argentina, Japan, France, Slovakia, Australia, Russian Federation, Bulgaria, Chile, Czech Republic
Sunovion

Completed

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose (RESOLVE 1)

Major Depressive Disorder With Mixed Features

United States, Serbia, Ukraine, Russian Federation, United Kingdom
Sunovion

Completed

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Bipolar Depression

United States, Canada, Czech Republic, India, Lithuania, Peru, South Africa, France, Poland, Romania, Russian Federation, Ukraine, Colombia, Slovakia, Japan
Sunovion

Completed

Major Depressive Disorder With Mixed Features - Extension (RESOLVE3)

Major Depressive Disorder

United States
Sunovion

Completed

Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects

Generalized Anxiety Disorder

United States
Sunovion

Completed

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. (PEARL 3)

Schizophrenia

United States, Russian Federation, India, Romania, Ukraine
Sunovion

Completed

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Epilepsy With Simple or Complex Partial Onset Seizures

United States, Canada
Sunovion

Completed

Lurasidone Pediatric Autism Study

Autism

United States
Sunovion

Completed

Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States, Israel, Chile, South Africa, Argentina, Brazil, Croatia, Thailand
Sunovion

Completed

Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia

Schizophrenia

United States, Lithuania, India, Philippines, Colombia
Sunovion

Completed

Dasotraline SEP360-105 Pediatric PK/PD Study

Pediatric Attention Deficit Hyperactivity Disorder

United States
Sunovion

Completed

Adult Attention Deficit Hyperactivity Disorder

Adult Attention Deficit Hyperactivity Disorder

United States
Sunovion

Completed

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

Bipolar Depression

United States, Czech Republic, India, France, Germany, Poland, Romania, Russian Federation, South Africa, Ukraine
Sunovion

Completed

A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia

Schizophrenia

United States
Sunovion

Completed

Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults

Type 2 Diabetes Mellitus

United States
Sunovion

Completed

Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Sunovion

Completed

Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray

Perennial Allergic Rhinitis

United States
Sunovion

Completed

Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia

Primary Insomnia
Sunovion

Completed

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older

Seasonal Allergic Rhinitis

United States
Sunovion

Completed

Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | Emphysema | Bronchitis

United States
Sunovion

Completed

A Safety, Efficacy and Tolerability Study of SEP-225289

Depressive Disorder, Major

United States
Sunovion

Completed

A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States
Sunovion

Completed

Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD)

Reactive Airways Disease (RAD)

United States, Canada
Sunovion

Completed

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects (POLARIS)

Asthma | COPD

United States
Sunovion

Completed

A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects

Asthma

United States
Sunovion

Completed

Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS)

Obstructive Sleep Apnea Syndrome

United States
Sunovion

Completed

Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma

Asthma

United States
Sunovion

Completed

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

Asthma

United States
Sunovion

Completed

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Asthma

United States
Sunovion

Completed

6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia

Primary Insomnia

United States
Sunovion

Completed

A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects (OC-DDI)

Pharmacokinetics

United States
Sunovion

Completed

The Bioequivalence Of Two Different Lurasidone Formulations In Patients

Schizophrenia

United States
Sunovion

Completed

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Canada
Sunovion

Completed

A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia

Schizophrenia

Hungary, United States, Romania, Ukraine, Russian Federation
Sunovion

Completed

Dasotraline Binge Eating Disorder Extension Study

Binge Eating Disorder

United States
Sunovion

Completed

A Study to Examine APL-130277 in Patients With Parkinson's Disease

Parkinson's Disease

United States
Sunovion

Completed

Pediatric Open-Label Extension Study

Schizophrenia | Bipolar Depression | Autism

Korea, Republic of, United States, Malaysia, Bulgaria, Poland, Mexico, Colombia, France, Hungary, Philippines, Puerto Rico, Romania, Russian Federation, Spain, Ukraine
Sunovion

Terminated

A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects

Chronic Obstructive Pulmonary Disease (COPD)

United States
Sunovion

Withdrawn

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Epilepsy

United States
Sunovion

Completed

Dasotraline Binge Eating Disorder Study

Binge Eating Disorder

United States
Sunovion

Completed

Pediatric Schizophrenia Efficacy and Safety Study

Schizophrenia

France, United States, Korea, Republic of, Poland, Spain, Puerto Rico, Colombia, Hungary, Bulgaria, Mexico, Malaysia, Philippines, Romania, Russian Federation, Ukraine, Belgium, United Kingdom

3

Subscribe